Gold vs US Dollar

Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.

Get Started

Home
Investing
Stocks
USA
NASDAQ
Travere Therapeutics Inc (TVTX)
Travere Therapeutics Inc (TVTX) Financials

TVTX Travere Therapeutics Inc

17.84

0.44 (2.53%)

21 Dec 2024 - Closed

Delayed by 15 minutes

Statistics

Annual Quarterly

Year End 31 December 2023	2016	2017	2018	2019	2020	2021	2022	2023
	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)
Return on Assets (%)	-9.26	-11.425	-16.702	-22.288	-27.953	-26.023	-38.432	-15.244
Return on Equity (%)	-15.811	-19.88	-33.589	-54.288	-78.366	-70.166	-161.456	-91.438
Return on Invested Capital (%)	-15.694	-13.033	-15.261	-16.972	-32.103	-29.31	-51.009	-74.652
Operating Margin (%)	-42.641	-36.902	-56.048	-72.785	-85.589	-70.131	-125.883	-251.157
Net Profit Margin (%)	-35.964	-38.552	-62.515	-83.511	-85.433	-79.164	-131.348	-76.701
Book Value Per Share	3.292	2.727	3.156	1.463	1.093	2.459	-1.589	1.282
Earnings Per Share	-1.267	-1.517	-2.481	-3.398	-3.243	-2.882	-4.332	-1.482
Cash Per Share	1.082	2.524	2.486	1.449	1.622	2.652	0.96	0.774
Working Capital Per Share	6.571	6.099	9.448	7.742	6.082	7.341	5.355	5.84
Operating Profit Per Share	3.404	3.843	3.841	4.365	3.679	3.532	3.18	1.78
EBIT Per Share	-1.523	-1.482	-2.461	-3.399	-3.613	-2.875	-4.327	-5.005
EBITDA Per Share	-1.523	-1.482	-2.461	-3.399	-3.613	-2.875	-4.327	-5.005
Free Cash Flow Per Share	-1.379	-1.613	-2.456	-3.511	-1.419	-2.921	-4.402	-1.432

Liquidity Ratios

Year End 31 December 2023	2016	2017	2018	2019	2020	2021	2022	2023
Current Ratio	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Quick Ratio	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Inventory Turnover (Days)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Shares Outstanding	37.91M	39.37M	41.39M	43.09M	52.25M	62.49M	64.29M	N/A

Key Stats and Ratios

Year End 31 December 2023	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024
	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)
Shares Outstanding	64.29M	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Return on Assets (%)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Return on Equity (%)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Return on Invested Capital (%)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Operating Margin (%)	N/A	-146.181	N/A	N/A	N/A	-321.378	N/A	N/A
Net Profit Margin (%)	N/A	-151.476	N/A	N/A	N/A	-328.856	N/A	N/A
Sales Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Book Value Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Earnings Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Cash Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Working Capital Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Operating Profit Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
EBIT Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
EBITDA Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Free Cash Flow Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Current Ratio	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Quick Ratio	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Inventory Turnover (Days)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

Key Stats and Ratios

Market Cap	1.36B
Price to Earnings Ratio	-12.04
Price to Sales Ratio	9.23
Price to Cash Ratio	23.05
Price to Book Ratio	6.68
Dividend Yield	-

Share Statistics

Shares Outstanding	78.05M
Average Volume (1 week)	1.48M
Average Volume (1 Month)	1.22M
52 Week Change	104.82%
52 Week High	20.33
52 Week Low	5.12

More Ratios Coming Soon!

Travere Therapeutics

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions